
Despite Gazyva being the first drug accepted to treat this type of nephropathy, it’s already approved for a host of other conditions.
Alzheimer?s disease (AD) is the most prevalent form of dementia in the U.S. According to statistics prepared by the Alzheimer?s Association, an estimated 4.5 million Americans have AD, and by 2050, 11.3 million to 16 million Americans will have the disease.






